Cargando…

Identification of Variants of Hepatitis C Virus (HCV) Entry Factors in Patients Highly Exposed to HCV but Remaining Uninfected: An ANRS Case-Control Study

Hepatitis C virus (HCV) causes persistent infection in 75% of cases and is a major public health problem worldwide. More than 92% of intravenous drug users (IDU) infected by human immunodeficiency virus type 1 (HIV-1) are seropositive for HCV, and it is conceivable that some HIV-1-infected IDU who r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fouquet, Baptiste, Ghosn, Jade, Quertainmont, Yann, Salmon, Dominique, Rioux, Christophe, Duvivier, Claudine, Delfraissy, Jean-François, Misrahi, Micheline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646460/ https://www.ncbi.nlm.nih.gov/pubmed/26571379 http://dx.doi.org/10.1371/journal.pone.0142698

Ejemplares similares

Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro
por: Fénéant, Lucie, et al.
Publicado: (2015)

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort
por: Billa, Oumar, et al.
Publicado: (2018)

Remaining challenges in HCV elimination
por: Capraru, Camelia, et al.
Publicado: (2021)

Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)
por: Antwerpes, Saskia, et al.
Publicado: (2020)

Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France)
por: Salmon-Ceron, Dominique, et al.
Publicado: (2012)

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study
por: Shili-Masmoudi, Sarah, et al.
Publicado: (2019)

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010
por: Loko, Marc-Arthur, et al.
Publicado: (2010)

HCV cure for everyone or which challenges remain?
por: Rockstroh, Jürgen Kurt
Publicado: (2015)

A Polymorphism in IL28B Distinguishes Exposed, Uninfected Individuals From Spontaneous Resolvers of HCV Infection
por: Knapp, Susanne, et al.
Publicado: (2011)

HCV entry receptors as potential targets for siRNA-based inhibition of HCV
por: Jahan, Shah, et al.
Publicado: (2011)

Targeting HCV Entry For Development of Therapeutics
por: Wong-Staal, Flossie, et al.
Publicado: (2010)

Lysosomotropic agents as HCV entry inhibitors
por: Ashfaq, Usman A, et al.
Publicado: (2011)

HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)
por: Barré, Tangui, et al.
Publicado: (2022)

Ovarian-like differentiation in eutopic and ectopic endometrioses with aberrant FSH receptor, INSL3 and GATA4/6 expression
por: Fouquet, Baptiste, et al.
Publicado: (2016)

Generation of fluorescent HCV pseudoparticles to study early viral entry events- involvement of Rab1a in HCV entry
por: Bhattacharjee, Chayan, et al.
Publicado: (2022)

Entry inhibitors: New advances in HCV treatment
por: Qian, Xi-Jing, et al.
Publicado: (2016)

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
por: Poizot-Martin, Isabelle, et al.
Publicado: (2015)

HCV and drug addiction in the historical scenario of infection entry in Italy
por: Massimo, Galli, et al.
Publicado: (2018)

Hepatitis C treatment initiation in HIV-HCV coinfected patients
por: Cotte, Laurent, et al.
Publicado: (2016)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Evolution of patients’ socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients
por: Yaya, Issifou, et al.
Publicado: (2018)

Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS CO-13 HEPAVIH Cohort)
por: Yaya, Issifou, et al.
Publicado: (2018)

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
por: Medvedev, Regina, et al.
Publicado: (2016)

Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study
por: Leprêtre, Annie, et al.
Publicado: (2015)

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study
por: Alric, Laurent, et al.
Publicado: (2016)

HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study
por: Duchesne, Léa, et al.
Publicado: (2017)

Development of global consensus sequence of HCV glycoproteins involved in viral entry
por: Idrees, Sobia, et al.
Publicado: (2013)

HCV and lichen planus: HCV and lichen planus
por: Rebora, Alfredo
Publicado: (2011)

HCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, California
por: Page, Kimberly, et al.
Publicado: (2017)

87. Heart and Lung Transplants From HCV-Viremic Donors to Uninfected Patients: Longer-Term Follow-Up
por: Woolley, Ann E, et al.
Publicado: (2019)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

HCV core antigen plays an important role in the fight against HCV as an alternative to HCV‐RNA detection
por: Wang, Yuhan, et al.
Publicado: (2021)

HCV resistance
por: Halfon, Philippe
Publicado: (2012)

HCV and Lymphoproliferation
por: Zignego, Anna Linda, et al.
Publicado: (2012)

MELD Score Kinetics in Decompensated HIV+/HCV+ Patients: A Useful Prognostic Tool (ANRS HC EP 25 PRETHEVIC Cohort Study)
por: Gelu-Simeon, Moana, et al.
Publicado: (2015)

High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262)
por: Nguyen Truong, Tam, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6vusjhj4oiq642d2ja22cgdhjv